BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 15166262)

  • 1. Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer.
    Mineo TC; Ambrogi V; Baldi A; Rabitti C; Bollero P; Vincenzi B; Tonini G
    J Clin Pathol; 2004 Jun; 57(6):591-7. PubMed ID: 15166262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy.
    Miyata Y; Mitsunari K; Asai A; Takehara K; Mochizuki Y; Sakai H
    Prostate; 2015 Jan; 75(1):84-91. PubMed ID: 25307287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis.
    Han H; Silverman JF; Santucci TS; Macherey RS; d'Amato TA; Tung MY; Weyant RJ; Landreneau RJ
    Ann Surg Oncol; 2001; 8(1):72-9. PubMed ID: 11206229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34.
    Miyata Y; Sagara Y; Watanabe S; Asai A; Matsuo T; Ohba K; Hayashi T; Sakai H
    Virchows Arch; 2013 Nov; 463(5):673-9. PubMed ID: 23975255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging proliferation of ¹⁸F-FLT PET/CT correlated with the expression of microvessel density of tumour tissue in non-small-cell lung cancer.
    Yang W; Zhang Y; Fu Z; Sun X; Mu D; Yu J
    Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1289-96. PubMed ID: 22581165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vascular endothelial growth factor expression and microvessel density in stage I-II non-small cell lung cancer and their prognostic significances].
    Zhu ZH; Rong TH; Zeng CG; Wu QL; Ma Y; Huang XP; Li BJ; Zhang PY; Zhao JM; Hu W; Zhang SY; Yu H; Ma GW; Zhang LJ; Wen ZS; Fu JH; Long H
    Ai Zheng; 2005 Jul; 24(7):865-9. PubMed ID: 16004817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of angiopoietins and its clinical significance in non-small cell lung cancer.
    Tanaka F; Ishikawa S; Yanagihara K; Miyahara R; Kawano Y; Li M; Otake Y; Wada H
    Cancer Res; 2002 Dec; 62(23):7124-9. PubMed ID: 12460935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of intratumoral microvascular density in patients with advanced non-small cell lung cancer receiving chemotherapy plus bevacizumab.
    Zhao YY; Xue C; Jiang W; Zhao HY; Huang Y; Feenstra K; Resau JH; Qian CN; Zhang L
    J Thorac Oncol; 2012 Jan; 7(1):71-5. PubMed ID: 22011670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma.
    Yang LY; Lu WQ; Huang GW; Wang W
    BMC Cancer; 2006 May; 6():110. PubMed ID: 16650286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor expression and neovascularisation in non-small cell lung cancer.
    Yano T; Tanikawa S; Fujie T; Masutani M; Horie T
    Eur J Cancer; 2000 Mar; 36(5):601-9. PubMed ID: 10738124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High vascularity in the peripheral region of non-small cell lung cancer tissue is associated with tumor progression.
    Ushijima C; Tsukamoto S; Yamazaki K; Yoshino I; Sugio K; Sugimachi K
    Lung Cancer; 2001 Nov; 34(2):233-41. PubMed ID: 11679182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.
    Tanaka F; Otake Y; Yanagihara K; Kawano Y; Miyahara R; Li M; Yamada T; Hanaoka N; Inui K; Wada H
    Clin Cancer Res; 2001 Nov; 7(11):3410-5. PubMed ID: 11705856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival.
    Decaussin M; Sartelet H; Robert C; Moro D; Claraz C; Brambilla C; Brambilla E
    J Pathol; 1999 Aug; 188(4):369-77. PubMed ID: 10440746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF.
    Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y
    Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study.
    Randall LM; Monk BJ; Darcy KM; Tian C; Burger RA; Liao SY; Peters WA; Stock RJ; Fruehauf JP
    Gynecol Oncol; 2009 Mar; 112(3):583-9. PubMed ID: 19110305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
    Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
    Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of angiogenesis with the expression of VEGF and CD34 in human non-small cell lung cancer.
    Inda AM; Andrini LB; García MN; García AL; Fernández Blanco A; Furnus CC; Galletti SM; Prat GD; Errecalde AL
    J Exp Clin Cancer Res; 2007 Sep; 26(3):375-8. PubMed ID: 17987799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor angiogenesis in predicting the survival of patients with stage I lung cancer.
    Medetoglu B; Gunluoglu MZ; Demir A; Melek H; Buyukpinarbasili N; Fener N; Dincer SI
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):996-1000. PubMed ID: 20708755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenetic protooncogene ets-1 induced neovascularization is involved in the metastatic process of testicular germ cell tumors.
    Adam M; Schmidt D; Wardelmann E; Wernert N; Albers P
    Eur Urol; 2003 Sep; 44(3):329-36. PubMed ID: 12932931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody.
    Yao Y; Kubota T; Takeuchi H; Sato K
    Neuropathology; 2005 Sep; 25(3):201-6. PubMed ID: 16193836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.